Home › Castration-Resistant Prostatic Cancer › Louisiana › Metairie
Castration-Resistant Prostatic Cancer clinical trials in Metairie, LA
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Metairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- East Jefferson General Hospital, Metairie
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- East Jefferson General Hospital, Metairie
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
RecruitingPhase 1/2
- East Jefferson General Hospital, River Ridge · 4 mi away
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Pittsburgh, PA4 studies
- Queens, NY4 studies
- Philadelphia, PA4 studies
- Mountain View, CA3 studies
- Cincinnati, OH3 studies
- Dallas, TX3 studies
- Minneapolis, MN3 studies
Other studies in Metairie
- Prostate Cancer12 studies
- Ulcerative Colitis8 studies
- Bladder Cancer6 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
- Steatotic Liver Disease4 studies
- Metastatic Cancer4 studies
- Cardiovascular Disease4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Neuroendocrine Tumors3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.